Fostering the development of AI-enhanced technologies to support healthy aging in place of choice for older adults and individuals with Alzheimer’s disease.
MassAITC announces call for applications for 6th Pilot Project Cohort!
MassAITC LOI Application Informational Webinar
Using AI to Repurpose Small Molecules to Target Amyloid-tau Interactions in AD
Investigators:
Jeremy Linsley, Operant BioPharma
An AI-powered Digital Therapy Assistant for Monitoring and Treating Cognitive Impairment
Investigators:
Jennifer Flexman, Moneta Health
Michael Busa, UMass Amherst
AI-Driven Early Detection of AD Risk Using Speech Features
Investigators:
Marziye Eshghi, MGH Institute of Health Professions
